Key takeaways from Marty Makary’s FDA confirmation hearing
Marty Makary, a career surgeon and President Trump’s nominee to run the Food and Drug Administration (FDA), faced senators in ...
BioSpace3d
Anxious Industry Awaits Makary’s Hearing Amid Disruptions, Layoffs at FDA
The Senate hearing for FDA Commissioner nominee Marty Makary comes after President Trump's NIH pick, Jay Bhattacharya, was ...
STAT5d
Wojcicki’s controversial bid to reclaim 23andMe
23andMe CEO Anne Wojcicki is attempting to buy her company back for a mere $42 million. It’s a fraction of the company’s ...
At the NIH, Intolerance Will No Longer Be Tolerated
Jay Bhattacharya has spent years railing against the National Institutes of Health. What happens when he runs it?
5 takeaways as Trump’s contrarian NIH pick faces senators
President Trump’s pick to lead the National Institutes of Health (NIH) faced questions from senators Wednesday on his plans ...
STAT3d
Amgen starts late-stage studies of MariTide
Elsewhere in the obesity space — Amgen has initiated Phase 3 trials of its obesity drug MariTide, one in overweight and obese ...
BioSpace2d
FDA Weathers Bait-and-Switch Storm as Staff and Sites Come and Go
Marty Makary, likely FDA commissioner under President Trump, appeared before Congress this week as the agency he’s set to ...
The New Republic on MSN5dOpinion
Here Come Two More Enemies of Science About to Lead Vital Agencies
A Senate committee this week will almost surely push forward the FDA and NIH nominees. Neither one has the public interest at ...
STAT5d
1 in 6 young people will have obesity by 2050, analysis predicts
Republicans trying to find billions of Medicaid dollars to pay for tax cuts now say that any reduction in Medicaid spending ...